← Leaderboards
Michelle L Hastings
Rosalind Franklin Univ Of Medicine & Sci
$5,202,184
Attributed
$8,438,592
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–23$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,438,592 · 4
By mechanism
R01$8,438,592 · 4
Top collaborators
- Penelope Jane Hallett5 shared
- Ole Isacson5 shared
- Jill M Weimer5 shared
Most similar at Rosalind Franklin Univ Of Medicine & Sci
Same institution · by research overlap
- Mallory Ann Havens$85,731
Others in their field
Top investigators on “Messenger Rna”
- Jeffrey P Krischer · University Of South Florida$206,732,287
- David Heimbrook · Leidos Biomedical Research, Inc.$96,474,613
- Henry F Chambers · Duke University$47,759,573
- Vance G Fowler · Duke University$46,487,462
- Barton F Haynes · Duke University$43,472,529
- Bradley F Boeve · Mayo Clinic Rochester$42,990,413
Research focus
Messenger RnaMutationProteinsRna SplicingAnimal ModelMrna PrecursorIn VitroIn VivoAntisense OligonucleotidesFunctional DisorderDesignCellsBaseAlzheimer&AposProductionMediatingNeuronsPathologyHuman Cell LineDementiaNerve DegenerationCognitiveBrainNeurodegenerative Disorders
Grant awards (19)
Reading Frame Correction for the Treatment of Batten Disease$581,344
R01 · FY2023 · NS · contact PI
Reading Frame Correction for the Treatment of Batten Disease$303,420
R01 · FY2023 · NS · contact PI
Prevention of complement and immune-mediated Lewy body dementia$563,846
R01 · FY2022 · AG
Reading Frame Correction for the Treatment of Batten Disease$555,821
R01 · FY2022 · NS · contact PI
Reading Frame Correction for the Treatment of Batten Disease$609,223
R01 · FY2021 · NS · contact PI
Prevention of complement and immune-mediated Lewy body dementia$569,300
R01 · FY2021 · AG
Prevention of complement and immune-mediated Lewy body dementia$574,594
R01 · FY2020 · AG
Reading Frame Correction for the Treatment of Batten Disease$572,075
R01 · FY2020 · NS · contact PI
Prevention of complement and immune-mediated Lewy body dementia$579,735
R01 · FY2019 · AG
Prevention of complement and immune-mediated Lewy body dementia$600,725
R01 · FY2018 · AG
Correction of Hearing and Vestibular Defects in a Mouse Model for Deafness$319,388
R01 · FY2016 · DC · contact PI
Correction of Hearing and Vestibular Defects in a Mouse Model for Deafness$316,194
R01 · FY2015 · DC · contact PI
Targeting SMN2 Alternative Splicing for the Treatment of Spinal Muscular Atrophy$326,836
R01 · FY2014 · NS · contact PI
Correction of Hearing and Vestibular Defects in a Mouse Model for Deafness$319,388
R01 · FY2014 · DC · contact PI
Correction of Hearing and Vestibular Defects in a Mouse Model for Deafness$330,969
R01 · FY2013 · DC · contact PI
Targeting SMN2 Alternative Splicing for the Treatment of Spinal Muscular Atrophy$318,583
R01 · FY2013 · NS · contact PI
Targeting SMN2 Alternative Splicing for the Treatment of Spinal Muscular Atrophy$330,138
R01 · FY2012 · NS · contact PI
Targeting SMN2 Alternative Splicing for the Treatment of Spinal Muscular Atrophy$330,138
R01 · FY2011 · NS · contact PI
Targeting SMN2 Alternative Splicing for the Treatment of Spinal Muscular Atrophy$336,875
R01 · FY2010 · NS · contact PI